Press Release Mangaluru: The Department of Pulmonary Medicine at KMC Hospital,Attavar will organize a free screening camp at its premises on 19th and 20th Dec 2014 between 9:00 am to 12:00 noon. People suffering from chronic cough due to excessive ... Mangalorean, 4 days ago
Ontario Lung Association Congratulates Dr. Arthur Slutsky, Recipient of the CIHR Researcher of the Year Award
The Ontario Lung Association salutes Dr. Arthur S. Slutsky, whose pioneering research in pulmonary medicine has earned him the prestigious 2014 Researcher of the Year award from the Canadian Institutes of Health Research. Dr. Slutsky, who is ...Individual.com, 6 days ago
Speaking to The Hindu, professor of Pulmonary Medicine, JSS Medical College, Mysuru, P.A. Mahesh, said several people tend to ignore their nasal allergies. About 30 to 50 per cent suffering from cold for a prolonged period without having fever are ...The Hindu, 1 week ago
GlaxoSmithKline said Thursday that it submitted a filing to the European Medicines Agency seeking to extend the indication for Volibris (ambrisentan) to include its use in initial combination therapy for patients with pulmonary arterial hypertension ...FirstWord Pharma, 1 week ago GSK seeks extended indication for pulmonary drug Invezz, 1 week ago GSK seeks EU marketing nod to use ambrisentan's extended indication to treat PAH PharmaBiz, 1 week ago GSK announces EU regulatory submission seeking extended indication for ambrisentan (Volibris®) in pulmonary arterial hypertension Noodls, 1 week ago
Medical Imaging : Investigators from University of Cambridge Zero in on Radiology (Multimodality imaging of pulmonary infarction)
By a News Reporter-Staff News Editor at Health & Medicine Week -- Current study results on Medical Imaging have been published. According to news reporting originating in Cambridge, United Kingdom , by NewsRx journalists, research stated, "The ...4 Traders, 4 days ago
NEW FINDINGS IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE DESCRIBED FROM NOVARTIS PHARMA (TURNING A MOLECULE INTO A MEDICINE : the Development of...
New Findings in Chronic Obstructive Pulmonary Disease Described from Novartis Pharma (Turning a Molecule into a Medicine: the Development of Indacaterol as a Novel Once-Daily Bronchodilator Treatment for Patients with COPD) By a News ...4 Traders, 1 week ago Greater Emphysema-like Lung on CT Linked to Mortality HCPLive, 5 days ago Vitamin D reduces lung disease flare-ups Jagran Post, 2 weeks ago Emphysema on CT Without COPD Predicts Higher Mortality Risk Medscape, 5 days ago
Merck & C : mpany Reports Findings in Pulmonary Medicine (Genetic regulation of gene expression in the lung identifies CST3 and CD22 as potential...
Merck & Company Reports Findings in Pulmonary Medicine (Genetic regulation of gene expression in the lung identifies CST3 and CD22 as potential causal genes for airflow obstruction) By a News Reporter-Staff News Editor at Health & Medicine Week ...4 Traders, 2 weeks ago
The Committee for Medicinal Products for Human Use recommended seven new medicines at a December 2014 meeting, including weight management and Parkinson's disease treatments. At the European Medicine's Agency Committee for Medicinal Products for ...PharmTech.com, 6 hours ago Seven new drugs recommended by EMA/CHMP in December 2014, 82 overall in 2014 Pharma Letter, 2 days ago News and press releases: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 15-18 December 2014 European Medicines Agency, 2 days ago Pending EC decision: Quinsair, levofloxacin, Opinion date: 18-Dec-2014 European Medicines Agency, 2 days ago
Human medicines European public assessment report (EPAR): Bretaris Genuair, aclidinium bromide, Revision: 8, Authorised
This is a summary of the European public assessment report (EPAR) for Bretaris Genuair. It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing ...European Medicines Agency, 3 days ago
The dispute is over manufacturing of the drug Indacaterol, used for treatment of chronic obstructive pulmonary disease Press Trust of India | New Delhi December 17, 2014 Last Updated at 20:24 IST The Delhi High Court has reserved its verdict on a ...Business Standard India, 4 days ago Pharmaceutical Newsletter - December 15 to 19, 2014 India Infoline, 3 days ago Delhi HC reserves order on Novartis-Cipla drug dispute Livemint.com, 4 days ago
More from: , New Indian Express...and 1 other sources
on your WebpageAdd Widget >Get your members hooked!